The mechanisms by which substances inhibit TPO can vary. Some compounds directly interfere with the enzyme's active site, preventing it from catalyzing the iodination process. Others may disrupt the overall structure of the enzyme or compete with iodine, thereby reducing its availability for hormone synthesis. Detailed investigations into these mechanisms help in developing strategies to mitigate adverse effects and improve the safety of chemical exposures.
